Study S002818

A Multicenter Extension Study of the Phase 3 Clinical Study of GZR18 Injection for Weight Loss

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07292441
Acronym: GZR18-BWM-303
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: DOUBLE
Status: RECRUITING
Enrollment: 500
Start: 2026-01-22
Primary completion: 2027-09
Lead sponsor: Gan & Lee Pharmaceuticals.
Conditions: Overweight or Obesity
Interventions: DRUG:GZR18 injection; OTHER:Placebo
Results posted: FALSE

Registered primary outcomes

Percent change (%) from baseline in body weight [from Week 0 (W0) to Week 24 (W24)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.